Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
Neurocrine Biosciences Reports Second Quarter 2009 Results
Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results
Neurocrine Biosciences Presents Elagolix Data
Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
Neurocrine Announces Work Force Restructuring
Neurocrine Biosciences Reports First Quarter 2009 Results
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
Zacks Analyst Blog Highlights: Baker Hughes, Inc., International Business Machines Corp., China Mobile Ltd. ADS, Neurocrine Biosciences, Inc. And Potash Corp. - Mar 27 2009 11:55PM
Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results - Feb 3 2009 8:05AM
Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results - Jan 27 2009 9:12PM
Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
Neurocrine Biosciences Reports Third Quarter 2008 Results
Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
invivodata Captures Symptom Relief Data in Endometriosis Trial
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
Neurocrine Biosciences Reports Second Quarter 2008 Results
Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference - Jun 1 2008 11:52PM
Neurocrine Biosciences Reports First Quarter 2008 Results
Webcast Alert: Neurocrine Announces 1Q08 Financial Results
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
Huntington's Therapeutics Reviewed by NeuroInvestment
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia